Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

Gene Expression Profiling in C57BL/6 Mice Treated with the Anorectic Drugs Sibutramine and Phendimetrazine and Their Mechanistic Implications

  • Ko, Moon-Jeong (Division of Molecular Pharmacology, Department of Pharmacological Research, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Choi, Hyo-Sung (Division of Molecular Pharmacology, Department of Pharmacological Research, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Ahn, Joon-Ik (Division of Molecular Pharmacology, Department of Pharmacological Research, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Kim, So-Young (Division of Molecular Pharmacology, Department of Pharmacological Research, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Jeong, Ho-Sang (Division of Molecular Pharmacology, Department of Pharmacological Research, National Institute of Toxicological Research, Korea Food and Drug Administration) ;
  • Chung, Hye-Joo (Division of Molecular Pharmacology, Department of Pharmacological Research, National Institute of Toxicological Research, Korea Food and Drug Administration)
  • Published : 2008.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, obesity has become a worldwide public health concern and the use of anorectic drugs has drastically increased. In this study, sibutramine and phendimetrazine, representative marketed anorectics, were repeatedly administered per os on a daily basis into C57BL/6 mice and the effects of these drugs on food intakes, body weight changes and gene expression profiles were monitored for up to following 7 days. Methamphetamine, which has a potent anorectic effect, was used as a positive control. Anorectic effects were sustained only for two days by phendimetrazine or methamphetamine, but for six days by sibutramine. The modulations of gene expressions in the hypothalamus and the striatum were investigated using microarrays on day 2 and day 7 post-administration, which corresponded to the anorectic period and a return of appetite respectively, for all three drugs tested. Differences in overall gene expression profiles in the stratum on day 2 for sibutramine and phendimetrazine seems to reflect difference between the two in terms of the onsets of drug tolerance. According to microarray findings, the Ankrd26 gene appears to have an important anorectic role, whereas the up-regulation of the olfaction system appeared to be involved in the drug tolerance of anorectics. The microarray data presented in this study demonstrates the usefulness of gene expression analysis for gathering information on the efficacy and safety of anorectic drugs.

Keywords

References

  1. Aime, P., Viret-Duchamp, P., Chaput, M.A., Savigner, A., Mahfouz, M., and Julliard, A.K. (2007). Fasting increases and satiation decreases olfactory detection for a neutral odor in rat. Behav. Brain Res. 179, 258-264 https://doi.org/10.1016/j.bbr.2007.02.012
  2. Alheid, G.F. (2003). Extended amygdale and basal forebrain. Ann. N. Y. Acad. Sci. 985, 185-702 https://doi.org/10.1111/j.1749-6632.2003.tb07082.x
  3. Apelbaum, A., Perrut, A., and Chaput, M. (2005). Orexin A effects on the olfactory bulb spontaneous activity and odor responsiveness in freely breathing rats. Regul. Pep. 129, 49-61 https://doi.org/10.1016/j.regpep.2005.01.003
  4. Balcioglu, A., and Wurtman, R.J. (2000). Sibutramine, a serotonin uptake inhibitor, increaseds dopamine concentrations in rat striatal and hypothalamic extracellular fluid. Neuropharmacology 39, 2352-2359 https://doi.org/10.1016/S0028-3908(00)00083-6
  5. Bera, T.K., Liu, X.F., Yamada, M., Gavrilova, O., Mezey, E., Tessarollo, L., Anver, M., Hahn, Y., Lee B., and Pastan, I. (2008). A model for obesity and gigantism due to distruption of the Ankrd26 gene. Proc. Natl. Acad. Sci. 105, 270-275 https://doi.org/10.1073/pnas.0710978105
  6. Buckett, W.R., Thomas, P.C., and Luscombe, G.P. (1988). The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog. Neuropsychopharacol. Biol. Psychiatry 12, 575-584 https://doi.org/10.1016/0278-5846(88)90003-6
  7. Chen, T.Y., Duh, S.L., Huang, C.C., Lin, T.B., and Kuo, D.Y. (2001). Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine. J. Boimed. Sci. 8, 462-466 https://doi.org/10.1007/BF02256608
  8. Chung, T.S., Chung, H.J., and Kim, J.H. (2007). PathTalk: Interpretation of microarray gene-expression clusters in association with biological pathways. Genomics & Inforamtics 5, 124-128
  9. Colman, E. (2005). Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann. Intern. Med. 143, 380-385 https://doi.org/10.7326/0003-4819-143-5-200509060-00013
  10. Connoley, I.P., Liu, Y.L., Frost, I., Reckless, I.P., Heal, D.J., and Stock, M.J. (1999). Thermogenic effects of sibutramine and its metabolites. Br. J. Pharmacol. 126, 1487-1496 https://doi.org/10.1038/sj.bjp.0702446
  11. Corwin, R.L., Woolverton, W.L., Schuster, C.R., and Johanson, C.E. (1987). Anorectics: effect on food intake and self-administration in rhesus monkeys. Alcohol Drug Res. 7, 351-361
  12. Evans, S.M., and Johanson, C.E. (1987). Amphetamine-like effects of anorectics and related compounds in pigeons. J. Pharmacol. Exp. Ther. 241, 817-825
  13. Gautvik, K.M., de Lecea, L., Gautivik, V.T., Danielson, P.E., Tranque, P., Dopazo, A., Bloom, F.E., and Sutcliffe, J.G. (1996). Overview of the most prevalent hypothal-amus-specific mRNAs, as identified by directional ta PCR subtraction. Proc. Natl. Acad. Sci. U.S.A. 93, 8733-8738 https://doi.org/10.1073/pnas.93.16.8733
  14. Grignaschi, G., Fanelli, E., Scagnol, I., and Samanin, R. (1999). Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various in rats. Br. J. Pharmacol. 127, 1190-1194 https://doi.org/10.1038/sj.bjp.0702633
  15. Gundlah, C., Martin, K.F., Heal, D.J., and Auerbach, S.B. (1997). In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents sibutramine is a reuptake inhibitor. J. Pharmacol. Exp. Ther. 283, 581-591
  16. Hahn, Y., Bera, T.K., Pastan, I.H., and Lee, B. (2006). Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domain. Gene 366, 238-245 https://doi.org/10.1016/j.gene.2005.07.045
  17. Halford, J.C.G., Wanninayake, S.C.D., and Blundell, J.E. (1998). Behavioural satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol. Biochem. Behav. 61, 159-168 https://doi.org/10.1016/S0091-3057(98)00032-X
  18. Janowitz, H.D., Hollander, F., and Marshar, R.H. (1953). The effect of tween-65 and tween 80 on gastrointestinal motility in man. Gastroenterology 24, 510-516
  19. Jones, D.N., and Holtzman, S.G. (1994). Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacology (Berlin) 114, 215-224 https://doi.org/10.1007/BF02244839
  20. Kuo, D.Y. (2003). Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerenral neuropeptide Y (NPY) in amphetamine-induced appetite suppression. Behav. Brain Res. 147, 149-155 https://doi.org/10.1016/j.bbr.2003.04.001
  21. Le Magnen, J. (1981). Neurophysiological basis for sensory mediated food selection. Criteria of Food Acceptance 268-280
  22. Lee, S.Y., Choi, M.K., Lim, J.M., Wu, H.G., Kim, J.H., and Park, W.Y. (2008) Differential expressions of apoptosis- related genes in lung cancer cell lines determine the responsiveness to ionizing radiation. Genomics & Inforamtics 6, 36-43 https://doi.org/10.5808/GI.2008.6.1.036
  23. Liu, Y.L., Heal, D.J., and Stock, M.J. (2002). Mechanism of the thermogenic effect of metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug sibutramine. Int. J. Obes. 26, 1245-1253 https://doi.org/10.1038/sj.ijo.0802062
  24. Mackler, S.A., and Eberwine, J.H. (1993). The molecular biology of additive drugs. Mol. Neurobiol. 5, 45-58 https://doi.org/10.1007/BF02935612
  25. Narnaware, Y.K., Peyon, P.P., Lin, X., and Peter, R.E. (2000). Regulating of food intake by neuropeptide Y in goldfish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1025-R1034 https://doi.org/10.1152/ajpregu.2000.279.3.R1025
  26. Narnaware, Y.K., and Peter, R.E. (2001). Effects of food deprivation and fefeeding on neuropeptide Y (NPY) mRNA levels in goldfish. Physiol. Behav. 74, 185-190 https://doi.org/10.1016/S0031-9384(01)00556-X
  27. Noailles, P.A., Becker, K.G., Wood, W.H., Teichberg, D., and Cadet, J.L. (2003). Methamphetamine-induced gene expression profiles in the striatum of male rat pups exposed to the drug in utero. Brain Res. Dev. Brain Res. 147, 152-162
  28. Robinson, T.E., and Berridge, K.C. (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18, 247-291 https://doi.org/10.1016/0165-0173(93)90013-P
  29. Rompre, P.P., and Wise, R.A. (1989). Behavioral evidence for midbrain dopamine depolarization inactivation. Brain Res. 16, 152-156
  30. Rothman, R.B., Katanelson, M., Vu, N., Partilla, J.S., Dersch, C.M., Blough, B.E., and Baumann, M.H. (2002). Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. European Journal of Pharmacology 447, 51-57 https://doi.org/10.1016/S0014-2999(02)01830-7
  31. Pager, J., Giachetti, I., Holley, A., and Le Magnen, J. (1972). A selective control of olfactory bulb electrical activity in relation to food deprivation and satiety in rats. Physiol. Behav. 9, 573-579 https://doi.org/10.1016/0031-9384(72)90014-5
  32. Saint-Cyr, J.A. (2003). Frontal-striatal circuit functions: context, sequence, and consequence, J. Int. Neuropsychol. Soc. 9, 103-127
  33. Saper, G.B., Chou, T.C., and Elmquist, J.K. (2002). The need to feed: homeostatic and hedonic control of eating. Neuron 36, 199-211 https://doi.org/10.1016/S0896-6273(02)00969-8
  34. Schwartz, P.J., Woods, S.C., Porte, D.Jr., Seeley, R.J., and Baskin, D.G. (2000). Central nervous system control of food intake. Nature 404, 661-671 https://doi.org/10.1038/35007534
  35. Seiden, L.S., Sabol, K.E., and Ricaurte, G.A. (1993). Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 23, 639-677
  36. Shu, J., Camacho, R., Gorski, J.N., Murphy, B., MacIntyre, E., and Hickey, G.J. (2002). Regulation of body weight and carcass composition by sibutramine in rats. Obesity Research 10, 173-181 https://doi.org/10.1038/oby.2002.27
  37. Silverstein, J.T., Breininger, J., Baskin, D.G., and Plisetskaya, E.M. (1998). Neuropeptide Y-like gene expression in the salmon brain increase with fasting. Gen. Comp. Endocrinol. 110, 157-165 https://doi.org/10.1006/gcen.1998.7058
  38. Stock, M. J. (1997). Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Int. J. Obes. Relat. Metab. Disord. 21, S23-29
  39. Williams, G., Harrold, J.A., and Gutler, D.J. (2000). The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc. Nut. Soc. 59, 385-396 https://doi.org/10.1017/S0029665100000434
  40. Yamamoto, H., Imai, K., Takamatsu, Y., Kamegaya, E., Kishida, M., Hagino, Y., Hara, Y., Shimada, K., Yamamoto, T., Sora, I., Hisashi, K., and Ikeda, K. (2005). Methamphetamine modulation of gene expression in the brain: Analysis using customized cDNA microarray system with the mouse homologues of KIAA genes. Molecular Brain Research 137, 40-46 https://doi.org/10.1016/j.molbrainres.2005.02.028

Cited by

  1. Analysis of Gene Expression in Mouse Spinal Cord-derived Neural Precursor Cells During Neuronal Differentiation vol.7, pp.2, 2009, https://doi.org/10.5808/GI.2009.7.2.085
  2. Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice vol.54, pp.11, 2011, https://doi.org/10.1007/s00125-011-2263-9